Blocking innate immunity to slow the progression of chronic kidney disease

Naunyn Schmiedebergs Arch Pharmacol. 2014 Oct;387(10):905-7. doi: 10.1007/s00210-014-1031-z. Epub 2014 Aug 10.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Interleukin-1 Receptor-Associated Kinases / antagonists & inhibitors*
  • Kidney Failure, Chronic / prevention & control*
  • Male
  • Nephrectomy*
  • Protein Kinase Inhibitors / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Protein Kinase Inhibitors
  • Interleukin-1 Receptor-Associated Kinases